中国P站

Preterm Infants; Neonatal Nutrition; Gut Health; Necrotizing Enterocolitis; Human Milk; Fortification; Probiotics; Parenteral Nutrition; Neurodevelopment; Microbiome

Introduction

This article reviews key nutritional strategies for improving gut health and preventing necrotizing enterocolitis (NEC) in preterm infants. It focuses on human milk benefits, specific formulas, and the roles of probiotics, prebiotics, and postbiotics in optimizing gut microbiome development and reducing NEC incidence through tailored interventions[1].

This narrative review summarizes recent advancements in the early nutritional care of very preterm infants. It covers optimized protein and energy intake, individualized feeding approaches, and the crucial role of human milk in supporting healthy growth, neurodevelopment, and long-term outcomes while minimizing complications[2].

This article provides an overview of parenteral nutrition (PN) in neonates, focusing on key components like amino acids, lipids, carbohydrates, and micronutrients. It discusses current guidelines, challenges, and strategies to optimize PN delivery to meet the unique metabolic needs of critically ill or extremely premature infants, promoting growth and minimizing complications[3].

This review provides recent insights into human milk fortification for preterm infants, crucial for meeting their high nutritional demands. It discusses various fortification methods, component considerations (protein, energy, minerals), and the balance between optimizing growth and preventing metabolic complications, offering future perspectives on individualized approaches[4].

This narrative review highlights recent advancements in protein and amino acid nutrition for preterm infants. It discusses the critical importance of optimal intake for growth and neurodevelopment, detailing current recommendations, challenges in achieving adequate provision, and emerging strategies for individualized supplementation[5].

This review explores the multifaceted role of human milk components, such as oligosaccharides, immunoglobulins, and lactoferrin, in shaping the neonatal gut microbiota and immune system. It emphasizes how these bioactive factors contribute to protection against infections, reduce inflammation, and promote healthy development in infants[6].

This narrative review examines the importance of omega-3 fatty acids, particularly DHA, in the nutrition of preterm infants. It discusses their critical role in brain and retinal development, current supplementation guidelines, and the challenges in achieving optimal intake to support neurodevelopmental outcomes in this vulnerable population[7].

This review explores the profound impact of the gut microbiome on neonatal nutrition and overall health. It discusses how early microbial colonization influences immune system development, nutrient metabolism, and susceptibility to diseases, emphasizing the role of maternal factors and feeding practices in shaping a healthy infant microbiome[8].

This article reviews current nutritional support strategies for critically ill neonates, covering both enteral and parenteral approaches. It highlights the challenges in providing adequate nutrition to these vulnerable infants, balancing aggressive feeding to promote growth with the risks of complications, and emphasizing individualized care plans[9].

This review explores the intricate relationship between early nutrition and the long-term growth and neurodevelopmental outcomes of extremely preterm infants. It emphasizes the critical window for nutritional interventions, discussing optimal macronutrient and micronutrient intake strategies to mitigate risks of impaired development and support healthier trajectories[10].

Description

The early nutritional care of very preterm and critically ill infants is paramount for fostering healthy growth, optimal neurodevelopment, and favorable long-term outcomes, all while meticulously minimizing potential complications. Recent advancements in early nutritional management underscore the necessity for optimized protein and energy intake, along with individualized feeding approaches, to support these vulnerable infants effectively [C002]. There is a recognized critical window for nutritional interventions in extremely preterm infants, where strategies for optimal macronutrient and micronutrient intake are crucial for mitigating the risks of impaired development and establishing healthier trajectories [C010]. Addressing the unique metabolic needs of these infants, nutritional support extends to critically ill neonates, involving both enteral and parenteral methods. The key challenge lies in providing adequate nourishment while balancing aggressive feeding with the inherent risks of complications, thus emphasizing the indispensable role of individualized care plans [C009].

A central theme in neonatal nutrition involves leveraging human milk and its multifaceted components. Specifically, oligosaccharides, immunoglobulins, and lactoferrin found in human milk are instrumental in shaping the neonatal gut microbiota and bolstering the immune system. These bioactive factors provide essential protection against infections, effectively reduce inflammation, and promote overall healthy development in infants [C006]. Building on this, nutritional strategies are specifically designed to improve gut health and prevent necrotizing enterocolitis (NEC) in preterm infants. These strategies capitalize on the benefits of human milk, utilize specific formulas, and integrate the roles of probiotics, prebiotics, and postbiotics to optimize gut microbiome development and significantly reduce the incidence of NEC through carefully tailored interventions [C001]. Additionally, the profound impact of the gut microbiome on neonatal nutrition and overall health, influencing immune system development, nutrient metabolism, and disease susceptibility, further emphasizes the critical influence of maternal factors and early feeding practices in establishing a healthy infant microbiome [C008].

Meeting the high nutritional demands of preterm infants often requires human milk fortification. Recent insights into fortification methods highlight component considerations, such as protein, energy, and minerals, to strike a delicate balance between optimizing growth and preventing metabolic complications. This area continues to evolve, offering future perspectives on highly individualized approaches [C004]. Furthermore, advances in protein and amino acid nutrition are continuously refining recommendations for preterm infants. Optimal intake is recognized as critically important for growth and neurodevelopment, with ongoing efforts to address challenges in achieving adequate provision and to develop emerging strategies for individualized supplementation [C005]. In parallel, omega-3 fatty acids, particularly Docosahexaenoic Acid (DHA), are indispensable in preterm infant nutrition, playing a critical role in brain and retinal development. Current supplementation guidelines are continually evaluated to overcome challenges in achieving optimal intake and support superior neurodevelopmental outcomes in this vulnerable population [C007].

For neonates who are critically ill or extremely premature and unable to tolerate sufficient enteral feeds, parenteral nutrition (PN) provides a vital form of nutritional support. This involves careful formulation of key components like amino acids, lipids, carbohydrates, and micronutrients. Discussion around current guidelines, challenges, and optimization strategies for PN delivery aims to meet the unique metabolic needs of these infants, thereby promoting growth and minimizing potential complications [C003]. In essence, the diverse range of nutritional strategies, from optimizing gut health to precise macronutrient provision and tailored parenteral support, collectively aims to enhance the overall health trajectory and developmental potential of preterm and critically ill neonates.

Conclusion

Research highlights crucial nutritional strategies for preterm and critically ill neonates, focusing on optimizing growth, neurodevelopment, and long-term health while preventing complications. Key interventions include promoting gut health and preventing necrotizing enterocolitis (NEC) through human milk benefits, specific formulas, and the roles of probiotics, prebiotics, and postbiotics in shaping the gut microbiome. Early nutritional management emphasizes optimized protein and energy intake, alongside individualized feeding approaches for very preterm infants. Parenteral nutrition (PN) in neonates is vital, with guidelines for amino acids, lipids, carbohydrates, and micronutrients to meet unique metabolic needs. Human milk fortification is essential to meet the high nutritional demands of preterm infants, balancing growth optimization with metabolic complication prevention. Advances in protein and amino acid nutrition are critical for growth and neurodevelopment, with emerging strategies for individualized supplementation. The multifaceted role of human milk components, such as oligosaccharides, immunoglobulins, and lactoferrin, in shaping neonatal gut microbiota and immune system is also explored, contributing to protection against infections and reducing inflammation. Omega-3 fatty acids, especially DHA, are important for brain and retinal development, with current guidelines addressing optimal intake. The profound impact of the gut microbiome on neonatal nutrition and health, influencing immune development and metabolism, underscores the importance of maternal factors and feeding practices. Finally, comprehensive nutritional support strategies for critically ill neonates encompass both enteral and parenteral approaches, advocating for individualized care plans to balance aggressive feeding with complication risks. Early nutrition significantly impacts long-term growth and neurodevelopmental outcomes in extremely preterm infants, emphasizing the critical window for intervention and optimal macronutrient/micronutrient intake strategies.

References

1. Chun Z, Xiao W, Ying S (2024) .Nutrients 16:718.

   , ,

2. Sara V, Giorgia B, Manuela A (2023) .Front Nutr 10:1162458.

   , ,

3. Arnauld L, Jacques R, Mary F (2022) .Front Nutr 9:964741.

   , ,

4. Sara V, Giorgia B, Margherita F (2023) .Nutrients 15:4967.

   , ,

5. Mary F, Jacques R, Arnauld L (2021) .Clin Nutr ESPEN 45:1-7.

   , ,

6. Nora TC, Layal A, Hady S (2024) .World J Clin Pediatr 13:1-13.

   , ,

7. Fabio M, Jacques R, Arnauld L (2021) .J Matern Fetal Neonatal Med 34:3671-3677.

   , ,

8. Razan RA, Abdulaziz SA, Shatha MA (2023) .Saudi J Med Med Sci 11:136-146.

   , ,

9. Silvia B, Laura C, Annamaria D (2022) .Children (Basel) 9:1693.

   , ,

10. Sara V, Giorgia B, Manuela A (2022) .Nutrients 14:4488.

    , ,